6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $242M | -$139M | 75.9% | -92.9% | $37M | $166M | $164M |
| 2024 | $252M | -$413M | 78.3% | -281.8% | $46M | $244M | $105M |
| 2023 | $251M | -$202M | 81.1% | -131.2% | $38M | $258M | $131M |
| 2022 | $223M | -$7M | 80.9% | -19.8% | $27M | $266M | $147M |
| 2021 | $166M | -$18M | 75.5% | -16.4% | $18M | $273M | $387M |
| 2020 | $118M | $0 | 74.2% | -13.4% | $22M | $462M | $25M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $56M | -$139M | 74.5% | -359.9% | $8M | $163M | $158M |
| Dec '25 | $62M | -$9M | 76.2% | -43.3% | -$2M | $166M | $164M |
| Sep '25 | $60M | -$15M | 76.6% | -14.5% | $13M | $167M | $108M |
| Jun '25 | $61M | -$8M | 76.7% | -6.9% | $7M | $169M | $81M |
| Mar '25 | $59M | -$107M | 73.9% | -312.2% | $18M | $171M | $106M |
| Dec '24 | $62M | -$59M | 76.4% | -159.8% | -$3M | $244M | $105M |
| Sep '24 | $63M | -$131M | 78.2% | -359.5% | $19M | $246M | $138M |
| Jun '24 | $64M | -$214M | 79.2% | -579.9% | $14M | $250M | $121M |
| Mar '24 | $63M | -$10M | 79.4% | -25.6% | $16M | $253M | $106M |
| Dec '23 | $66M | -$10M | 81.0% | -15.3% | $4M | $258M | $131M |
| Sep '23 | $65M | -$172M | 81.8% | -452.2% | $9M | $260M | $77M |
| Jun '23 | $61M | -$9M | 81.7% | -19.8% | $11M | $261M | $132M |
| Mar '23 | $59M | -$12M | 79.9% | -20.7% | $14M | $263M | $125M |
| Dec '22 | $61M | $10M | 83.8% | -17.4% | -$9M | $266M | $147M |
| Sep '22 | $57M | -$3M | 83.1% | -17.5% | $9M | $266M | $229M |
| Jun '22 | $55M | -$5M | 78.4% | -21.8% | $15M | $268M | $228M |
| Mar '22 | $50M | -$9M | 77.4% | -21.9% | $13M | $269M | $230M |
| Dec '21 | $46M | -$10M | 76.5% | -28.3% | — | $273M | $387M |
| Sep '21 | $43M | -$8M | 75.7% | -10.8% | — | $272M | $190M |
| Jun '21 | $40M | $0 | 75.2% | -17.5% | — | — | — |
How the market has priced DH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Definitive Healthcare Corp.'s revenue has grown 15.3% per year. These are computed facts, not advice.
As of FY2025, Definitive Healthcare Corp. reported $166M of total debt against $164M of cash; operating income covered interest expense -19.9×.
In FY2025, gross margin was 75.9%, operating margin -92.9%, and net margin -57.5%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.